Interests: Stem Cell treatments for Diabetes
During her undergraduate degree in Biomedical Science, Karen spent a year working in the pharmaceutical industry in a diabetes drug development team and has been interested in diabetes and diseases of glucose homeostasis ever since. She gained her PhD at the University of Sheffield studying a rare disease of the pancreas called Congenital Hyperinsulinism in Infancy (CHI). After her PhD she was a Post-Doctoral researcher for three years before becoming an Independent Research Fellow and leading her own research group. Today she is a Lecturer at the University of Manchester. She became interested in stem cells at the end of her PhD and has since been actively researching how stem cells might eventually lead to new treatments for people with diabetes via pancreas regeneration or transplantation of stem cell derived insulin-producing cells.